Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
19
10
2020
accepted:
15
12
2020
revised:
15
12
2020
pubmed:
3
2
2021
medline:
27
1
2022
entrez:
2
2
2021
Statut:
ppublish
Résumé
The Genitourinary Pathology Society (GUPS) undertook a critical review of the recent advances in renal neoplasia, particularly focusing on the newly accumulated evidence post-2016 World Health Organization (WHO) classification. In the era of evolving histo-molecular classification of renal neoplasia, morphology is still key. However, entities (or groups of entities) are increasingly characterized by specific molecular features, often associated either with recognizable, specific morphologies or constellations of morphologies and corresponding immunohistochemical profiles. The correct diagnosis has clinical implications leading to better prognosis, potential clinical management with targeted therapies, may identify hereditary or syndromic associations, which may necessitate appropriate genetic testing. We hope that this undertaking will further facilitate the identification of these entities in practice. We also hope that this update will bring more clarity regarding the evolving classification of renal neoplasia and will further reduce the category of "unclassifiable renal carcinomas/tumors". We propose three categories of novel entities: (1) "Novel entity", validated by multiple independent studies; (2) "Emerging entity", good compelling data available from at least two or more independent studies, but additional validation is needed; and (3) "Provisional entity", limited data available from one or two studies, with more work required to validate them. For some entities initially described using different names, we propose new terminologies, to facilitate their recognition and to avoid further diagnostic dilemmas. Following these criteria, we propose as novel entities: eosinophilic solid and cystic renal cell carcinoma (ESC RCC), renal cell carcinoma with fibromyomatous stroma (RCC FMS) (formerly RCC with leiomyomatous or smooth muscle stroma), and anaplastic lymphoma kinase rearrangement-associated renal cell carcinoma (ALK-RCC). Emerging entities include: eosinophilic vacuolated tumor (EVT) and thyroid-like follicular renal cell carcinoma (TLFRCC). Finally, as provisional entities, we propose low-grade oncocytic tumor (LOT), atrophic kidney-like lesion (AKLL), and biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC).
Identifiants
pubmed: 33526874
doi: 10.1038/s41379-021-00737-6
pii: S0893-3952(22)00606-8
doi:
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
1167-1184Commentaires et corrections
Type : ErratumIn
Références
Perrino CM, Grignon DJ, Williamson SR, Idrees MT, Eble JN, Cheng L. Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases. Histopathology. 2018;72:305–19.
pubmed: 28833389
Andeen NK, Qu X, Antic T, Tykodi SS, Fang M, Tretiakova MS. Clinical utility of chromosome genomic array testing for unclassified and advanced-stage renal cell carcinomas. Arch Pathol Lab Med. 2019;143:494–504.
pubmed: 30383394
Chen YB, Xu J, Skanderup AJ, Dong Y, Brannon AR, Wang L, et al. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nat Commun. 2016;7:13131.
pubmed: 27713405
pmcid: 5059781
Li Y, Reuter VE, Matoso A, Netto GJ, Epstein JI, Argani P. Re-evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients. Histopathology. 2018;72:588–600.
pubmed: 28898443
Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, et al. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Hum Pathol. 2019;91:114–22.
pubmed: 31299266
pmcid: 7528421
Guo J, Tretiakova MS, Troxell ML, Osunkoya AO, Fadare O, Sangoi AR, et al. Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol. 2014;38:1457–67.
pubmed: 25093518
Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, Xiao Y, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895–909.
pubmed: 24832166
pmcid: 4139167
Trpkov K, Hes O, Bonert M, Lopez JI, Bonsib SM, Nesi G, et al. Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women. Am J Surg Pathol. 2016;40:60–71.
pubmed: 26414221
Trpkov K, Abou-Ouf H, Hes O, Lopez JI, Nesi G, Comperat E, et al. Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity. Am J Surg Pathol. 2017;41:1299–308.
pubmed: 28786877
Parilla M, Kadri S, Patil SA, Ritterhouse L, Segal J, Henriksen KJ, et al. Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations? Am J Surg Pathol. 2018;42:911–7.
pubmed: 29668487
Palsgrove DN, Li Y, Pratilas CA, Lin MT, Pallavajjalla A, Gocke C, et al. Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum. Am J Surg Pathol. 2018;42:1166–81.
pubmed: 29975249
pmcid: 6089659
Trpkov K, Bonert M, Gao Y, Kapoor A, He H, Yilmaz A, et al. High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex. Histopathology. 2019;75:440–2.
pubmed: 31002177
Trpkov K, Hes O. New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology. 2019;74:31–59.
pubmed: 30565301
Siadat F, Trpkov K. ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification. Cancers. 2020;12:168.
pmcid: 7017067
Shah RB, Stohr BA, Tu ZJ, Gao Y, Przybycin CG, Nguyen J, et al. “Renal Cell Carcinoma With Leiomyomatous Stroma” Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity. Am J Surg Pathol. 2020;44:571–81.
pubmed: 31850909
Schultz L, Chaux A, Albadine R, Hicks J, Kim JJ, De Marzo AM, et al. Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol. 2011;35:1549–56.
pubmed: 21881486
pmcid: 3505672
Kwiatkowski DJ, Choueiri TK, Fay AP, Rini BI, Thorner AR, de Velasco G, et al. Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2016;22:2445–52.
pubmed: 26831717
pmcid: 4976069
Roldan-Romero JM, Santos M, Lanillos J, Caleiras E, Anguera G, Maroto P, et al. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome. Mod Pathol. 2020;33:2580–90.
pubmed: 32616874
Chaux A, Albadine R, Schultz L, Hicks J, Carducci MA, Argani P, et al. Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas. Hum Pathol. 2013;44:2323–30.
pubmed: 23953228
Shah A, Lal P, Toorens E, Palmer MB, Schwartz L, Vergara N, et al. Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes. Am J Surg Pathol. 2020;44:1479–86.
pubmed: 32604168
Mehra R, Vats P, Cao X, Su F, Lee ND, Lonigro R, et al. Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma. Eur Urol. 2018;74:483–6.
pubmed: 29941307
pmcid: 6390848
Schreiner A, Daneshmand S, Bayne A, Countryman G, Corless CL, Troxell ML. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int J Surg Pathol. 2010;18:409–18.
pubmed: 19403547
Park JH, Lee C, Chang MS, Kim K, Choi S, Lee H, et al. Molecular characterization and putative pathogenic pathways of tuberous sclerosis complex-associated renal cell carcinoma. Transl Oncol. 2018;11:962–70.
pubmed: 29925043
pmcid: 6008483
Tretiakova MS. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases. Hum Pathol. 2018;80:65–75.
pubmed: 29885406
McKenney JK, Przybycin C, Trpkov K, Magi-Galluzzi C. Eosinophilic solid and cystic (ESC) renal cell carcinomas have metastatic potential. Histopathology. 2018;72:1066–7.
pubmed: 29265482
Eich ML, Tregnago AC, Faraj SF, Palsgrove DN, Fujita K, Bezerra SM, et al. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma. Virchows Arch. 2019;474:21–7.
pubmed: 30338346
Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–93.
pubmed: 22500797
pmcid: 3331679
Falzarano SM, McKenney JK, Montironi R, Eble JN, Osunkoya AO, Guo J, et al. Renal cell carcinoma occurring in patients with prior neuroblastoma: a heterogenous group of neoplasms. Am J Surg Pathol. 2016;40:989–97.
pubmed: 26975037
Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumours of the urinary system and male genital organs. 4th ed. Lyon, France: International Agency for Research on Cancer; 2016.
Parilla M, Alikhan M, Al-Kawaaz M, Patil S, Kadri S, Ritterhouse LL, et al. Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma. Am J Surg Pathol. 2019;43:1135–44.
pubmed: 30986793
Peckova K, Grossmann P, Bulimbasic S, Sperga M, Perez Montiel D, Daum O, et al. Renal cell carcinoma with leiomyomatous stroma–further immunohistochemical and molecular genetic characteristics of unusual entity. Ann Diagn Pathol. 2014;18:291–6.
pubmed: 25175809
Petersson F, Martinek P, Vanecek T, Pivovarcikova K, Peckova K, Ondic O, et al. Renal'ma: a group of tumors with indistinguishable histopathologic features, but 2 distinct genetic profiles: next-generation sequencing analysis of 6 cases negative for aberrations related to the VHL gene. Appl Immunohistochem Mol Morphol 2018;26:192–7.
pubmed: 29084058
Lan TT, Keller-Ramey J, Fitzpatrick C, Kadri S, Taxy JB, Segal JP, et al. Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block. Virchows Arch. 2016;469:81–91.
pubmed: 27173781
Williamson SR. Renal cell carcinomas with a mesenchymal stromal component: what do we know so far? Pathology. 2019;51:453–62.
pubmed: 31266596
Williamson SR, Cheng L, Eble JN, True LD, Gupta NS, Wang M, et al. Renal cell carcinoma with angioleiomyoma-like stroma: clinicopathological, immunohistochemical, and molecular features supporting classification as a distinct entity. Mod Pathol. 2015;28:279–94.
pubmed: 25189644
Petersson F, Branzovsky J, Martinek P, Korabecna M, Kruslin B, Hora M, et al. The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process. Virchows Arch. 2014;465:89–96.
pubmed: 24838683
Hakimi AA, Tickoo SK, Jacobsen A, Sarungbam J, Sfakianos JP, Sato Y, et al. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype. Mod Pathol. 2015;28:845–53.
pubmed: 25676555
pmcid: 4449825
DiNatale RG, Gorelick AN, Makarov V, Blum KA, Silagy AW, Freeman B, et al. Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course. Eur Urol Focus. 2019 [Epub ahead of print].
He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, et al. “High-grade oncocytic renal tumor”: morphologic, immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch. 2018;473:725–38.
pubmed: 30232607
Chen YB, Mirsadraei L, Jayakumaran G, Al-Ahmadie HA, Fine SW, Gopalan A, et al. Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol. 2019;43:121–31.
pubmed: 30303819
pmcid: 6686675
Tjota M, Chen H, Parilla M, Wanjari P, Segal J, Antic T. Eosinophilic renal cell tumors With a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study. Am J Surg Pathol. 2020;44:943–54.
pubmed: 32091432
Trpkov K, Williamson SR, Gao Y, Martinek P, Cheng L, Sangoi AR, et al. Low-grade oncocytic tumor of kidney (CD117 negative, cytokeratin 7 positive): a distinct entity? Histopathology. 2019;75:174–84.
pubmed: 30895640
Guo Q, Liu N, Wang F, Guo Y, Yang B, Cao Z, et al. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China. Virchows Arch. 2020. [Epub ahead of print].
Paner G, Amin M, Moch H, Storke lS. Chromophobe renal cell carcinoma. In: Moch HHP, Ulbright TM, Reuter VE, editors. WHO classification of tumours of the urinary system and male genital organs: Lyon: International Agency for Research on Cancer; 2016. p. 27–8.
Wobker SE, Williamson SR. Modern pathologic diagnosis of renal oncocytoma. J Kidney Cancer Vhl. 2017;4:1–12.
pubmed: 29090117
pmcid: 5634396
Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26:319–30.
pubmed: 25155756
pmcid: 4160352
Tong K, Hu Z. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry. Virchows Arch. 2020. [Epub ahead of print].
Skala SL, Wang X, Zhang Y, Mannan R, Wang L, Narayanan SP, et al. Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms. Eur Urol. 2020;78:63–74.
pubmed: 32299640
Hallberg B, Palmer RH. Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer. 2013;13:685–700.
Pal SK, Bergerot P, Dizman N, Bergerot C, Adashek J, Madison R, et al. Responses to alectinib in ALK-rearranged papillary renal cell carcinoma. Eur Urol 2018;74:124–8.
pubmed: 29685646
Tao J, Wei G, Patel R, Fagan P, Hao X, Bridge J, et al. ALK fusions in renal cell carcinoma: response to entrectinib. JCO Precis Oncol. 2018;2:1–8.
Marino-Enriquez A, Ou WB, Weldon CB, Fletcher JA, Perez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011;50:146–53.
pubmed: 21213368
Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, et al. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol. 2011;24:430–42.
pubmed: 21076462
Sugawara E, Togashi Y, Kuroda N, Sakata S, Hatano S, Asaka R, et al. Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer. 2012;118:4427–36.
pubmed: 22252991
Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, et al. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol. 2012;25:1516–25.
pubmed: 22743654
Lee C, Park JW, Suh JH, Nam KH, Moon KC. ALK-positive renal cell carcinoma in a large series of consecutively resected korean renal cell carcinoma patients. Korean J Pathol. 2013;47:452–7.
pubmed: 24255633
pmcid: 3830992
Smith NE, Deyrup AT, Marino-Enriquez A, Fletcher JA, Bridge JA, Illei PB, et al. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol. 2014;38:858–63.
pubmed: 24698962
pmcid: 4352307
Ryan C, Mayer N, Cunningham J, Hislop G, Pratt N, Fleming S. Increased ALK1 copy number and renal cell carcinoma-a case report. Virchows Arch. 2014;464:241–5.
pubmed: 24318419
Cajaiba MM, Jennings LJ, Rohan SM, Perez-Atayde AR, Marino-Enriquez A, Fletcher JA, et al. ALK-rearranged renal cell carcinomas in children. Genes Chromosomes Cancer. 2016;55:442–51.
pubmed: 26773439
Cajaiba MM, Jennings LJ, George D, Perlman EJ. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: identification of a novel HOOK1-ALK fusion transcript. Genes Chromosomes Cancer. 2016;55:814–7.
pubmed: 27225638
pmcid: 4980203
Thorner PS, Shago M, Marrano P, Shaikh F, Somers GR. TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: report of a case with a TPM3-ALK translocation. Pathol Res Pract. 2016;212:937–42.
pubmed: 27450657
Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, et al. Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene. Am J Surg Pathol. 2016;40:761–9.
pubmed: 26848800
Jeanneau M, Gregoire V, Desplechain C, Escande F, Tica DP, Aubert S, et al. ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult. Pathol Res Pract. 2016;212:1064–6.
pubmed: 27554841
Oyama Y, Nishida H, Kusaba T, Kadowaki H, Arakane M, Daa T, et al. A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma. Pathol Int. 2017;67:626–31.
pubmed: 29024210
Yu W, Wang Y, Jiang Y, Zhang W, Li Y. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review. Histopathology. 2017;71:53–62.
pubmed: 28199742
Bodokh Y, Ambrosetti D, Kubiniek V, Tibi B, Durand M, Amiel J, et al. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review. Cancer Genet. 2018;221:31–7.
pubmed: 29405994
Yang J, Dong L, Du H, Li XB, Liang YX, Liu GR. ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review. Diagn Pathol. 2019;14:112.
pubmed: 31627758
pmcid: 6798478
Wang XT, Fang R, Ye SB, Zhang RS, Li R, Wang X, et al. Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait. Pathol Res Pract. 2019;215:152651.
pubmed: 31563285
Kuroda N, Trpkov K, Gao Y, Tretiakova M, Liu YJ, Ulamec M, et al. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217. Mod Pathol. 2020;33:2564–79.
pubmed: 32467651
Hang JF, Chung HJ, Pan CC. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology. Virchows Arch. 2020;476:921–9.
pubmed: 31993771
Agrawal V, Neyaz Z, Kapoor R. Thyroid-like follicular carcinoma of the kidney with oncocytic cells: a case report and review of metastatic and non-metastatic tumors. Int J Surg Pathol. 2020;28:913–7.
pubmed: 32484016
Amin MB, Gupta R, Ondrej H, McKenney JK, Michal M, Young AN, et al. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009;33:393–400.
pubmed: 19047894
Chen F, Wang Y, Wu X, Zhu Y, Jiang X, Chen S, et al. Clinical characteristics and pathology of thyroid-like follicular carcinoma of the kidney: report of 3 cases and a literature review. Mol Clin Oncol. 2016;4:143–50.
pubmed: 26893850
Alessandrini L, Fassan M, Gardiman MP, Guttilla A, Zattoni F, Galletti TP. Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. Virchows Arch. 2012;461:345–50.
pubmed: 22898790
Cavalcante A, Kuwano AY, Costa-Matos A, Spanholi EF, Souza T, Mascarenhas FM. Thyroid-like follicular carcinoma of the kidney - Case report. Urol Case Rep. 2017;15:36–8.
pubmed: 28948155
pmcid: 5602887
Chougule A, Bal A, Das A, Nayak B. Thyroid-like follicular renal cell carcinoma: an emerging morphological variant. Pathology. 2014;46:657–60.
pubmed: 25393263
Dawane R, Grindstaff A, Parwani AV, Brock T, White WM, Nodit L. Thyroid-like follicular carcinoma of the kidney: one case report and review of the literature. Am J Clin Pathol. 2015;144:796–804.
pubmed: 26486745
Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011;42:146–50.
pubmed: 20971497
Dhillon J, Mohanty SK, Krishnamurthy S. Cytologic diagnosis of thyroid-like follicular carcinoma of the kidney: a case report. Diagn Cytopathol 2014;42:273–7.
pubmed: 23166108
Dong L, Huang J, Huang L, Shi O, Liu Q, Chen H, et al. Thyroid-like follicular carcinoma of the kidney in a patient with skull and meningeal Metastasis: a unique case report and review of the literature. Medicine. 2016;95:e3314.
pubmed: 27082575
pmcid: 4839819
Ghaouti M, Roquet L, Baron M, Pfister C, Sabourin JC. Thyroid-like follicular carcinoma of the kidney: a case report and review of the literature. Diagn Pathol. 2014;9:186.
pubmed: 25293503
pmcid: 4190304
Jenkins TM, Rosenbaum J, Zhang PJ, Schwartz LE, Nayak A, Cooper K, et al. Thyroid-like follicular carcinoma of the kidney with extensive sarcomatoid differentiation: a case report and review of the literature. Int J Surg Pathol. 2019;27:678–83.
pubmed: 31032708
de Jesus LE, Fulgencio C, Leve T, Dekermacher S. Thyroid-like follicular carcinoma of the kidney presenting on a 10 year-old prepubertal girl. Int Braz J Urol. 2019;45:834–42.
pubmed: 31063281
pmcid: 6837619
Khoja HA, Almutawa A, Binmahfooz A, Aslam M, Ghazi AA, Almaiman S. Papillary thyroid carcinoma-like tumor of the kidney: a case report. Int J Surg Pathol. 2012;20:411–5.
pubmed: 22158951
Li C, Dong H, Fu W, Qi M, Han B. Thyroid-like follicular carcinoma of the kidney and papillary renal cell carcinoma with thyroid-like feature: comparison of two cases and literature review. Ann Clin Lab Sci. 2015;45:707–12.
pubmed: 26663803
Lin YZ, Wei Y, Xu N, Li XD, Xue XY, Zheng QS, et al. Thyroid-like follicular carcinoma of the kidney: a report of two cases and literature review. Oncol Lett. 2014;7:1796–802.
pubmed: 24932236
pmcid: 4049768
Vicens RA, Balachandran A, Guo CC, Vikram R. Multimodality imaging of thyroid-like follicular renal cell carcinoma with lung metastases, a new emerging tumor entity. Abdom Imaging. 2014;39:388–93.
pubmed: 24343809
Malde S, Sheikh I, Woodman I, Fish D, Bilagi P, Sheriff MK. Primary thyroid-like follicular renal cell carcinoma: an emerging entity. Case Rep Pathol. 2013;2013:687427.
pubmed: 23533895
pmcid: 3594949
Volavsek M, Strojan-Flezar M, Mikuz G. Thyroid-like follicular carcinoma of the kidney in a patient with nephrolithiasis and polycystic kidney disease: a case report. Diagn Pathol. 2013;8:108.
pubmed: 23819507
pmcid: 3751076
Wang H, Yu J, Xu Z, Li G. Clinicopathological study on thyroid follicular carcinoma-like renal tumor related to serious hypertension: Case report and review of the literature. Medicine. 2017;96:e6419.
pubmed: 28328844
pmcid: 5371481
Sterlacci W, Verdorfer I, Gabriel M, Mikuz G. Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic, and scintigraphic studies. Virchows Arch. 2008;452:91–5.
pubmed: 17704942
Wu WW, Chu JT, Nael A, Rezk SA, Romansky SG, Shane L. Thyroid-like follicular carcinoma of the kidney in a young patient with history of pediatric acute lymphoblastic leukemia. Case Rep Pathol. 2014;2014:313974.
pubmed: 25133003
pmcid: 4123569
Zhang Y, Yang J, Zhang M, Meng Z, Song W, Yang L, et al. Thyroid follicular carcinoma-like renal tumor: a case report and literature review. Medicine. 2018;97:e10815.
pubmed: 29794767
pmcid: 6392547
Jung SJ, Chung JI, Park SH, Ayala AG, Ro JY. Thyroid follicular carcinoma-like tumor of kidney: a case report with morphologic, immunohistochemical, and genetic analysis. Am J Surg Pathol. 2006;30:411–5.
pubmed: 16538064
Fanelli GN, Fassan M, Dal Moro F, Soligo M, Munari G, Zattoni F, et al. Thyroid-like follicular carcinoma of the kidney: the mutational profiling reveals a BRAF wild type status. Pathol Res Pract. 2019;215:152532.
pubmed: 31345592
Ohe C, Kuroda N, Pan CC, Yang XJ, Hes O, Michal M, et al. A unique renal cell carcinoma with features of papillary renal cell carcinoma and thyroid-like carcinoma: a morphological, immunohistochemical and genetic study. Histopathology. 2010;57:494–7.
pubmed: 20727022
Fadare O, Lam S, Rubin C, Renshaw IL, Nerby CL. Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas. Ann Diagn Pathol. 2010;14:284–91.
pubmed: 20637436
Tretiakova MS, Kehr EL, Gore JL, Tykodi SS. Thyroid-like follicular renal cell carcinoma arising within benign mixed epithelial and stromal tumor. Int J Surg Pathol. 2020;28:80–6.
pubmed: 31342803
Hes O, de Souza TG, Pivovarcikova K, Grossmann P, Martinek P, Kuroda N, et al. Distinctive renal cell tumor simulating atrophic kidney with 2 types of microcalcifications. Report of 3 cases. Ann Diagn Pathol. 2014;18:82–8.
pubmed: 24456861
Muscara MJ, Simper NB, Gandia E. Thyroid-like follicular carcinoma of the kidney. Int J Surg Pathol. 2017;25:73–7.
pubmed: 27474044
Ko JJ, Grewal JK, Ng T, Lavoie JM, Thibodeau ML, Shen Y, et al. Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma. Cold Spring Harb Mol Case Stud. 2018;4:a0031137.
Rao V, Menon S, Bakshi G, Prakash G, Agarwal A, Desai S. Thyroid-like follicular carcinoma of the kidney with low-grade sarcomatoid component: a hitherto undescribed case. Int J Surg Pathol. 2020. https://doi.org/10.1177/1066896920940406 .
Oshiro Y, Hida AI, Tamiya S, Toyoshima S, Kuroda N, Hes O, et al. Bilateral atrophic kidney-like tumors. Pathol Int 2014;64:478–80.
pubmed: 25146563
Herlitz L, Hes O, Michal M, Tretiakova M, Reyes-Mugica M, Nguyen JK, et al. “Atrophic Kidney”-like Lesion: clinicopathologic series of 8 cases supporting a benign entity distinct from thyroid-like follicular carcinoma. Am J Surg Pathol. 2018;42:1585–95.
pubmed: 30285996
Berens S, Vogt P, Alkadhi H, Berger N, Moch H. [Thyroid-like follicular carcinoma of the kidney: a separate tumor entity?]. Pathologe. 2014;35:83–7.
pubmed: 23732632
Argani P, Reuter VE, Eble JN, Vlatkovic L, Yaskiv O, Swanson D, et al. Biphasic hyalinizing psammomatous renal cell carcinoma (BHP RCC): a distinctive neoplasm associated with somatic NF2 mutations. Am J Surg Pathol. 2020;44:901–16.
pubmed: 32217839
pmcid: 7350624